Compare ELVN & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELVN | NMRK |
|---|---|---|
| Founded | 2016 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 2020 | 2017 |
| Metric | ELVN | NMRK |
|---|---|---|
| Price | $41.67 | $14.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $43.40 | $18.75 |
| AVG Volume (30 Days) | 570.7K | ★ 1.4M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | 3.17 | ★ 100.00 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $3,294,024,000.00 |
| Revenue This Year | N/A | $12.45 |
| Revenue Next Year | N/A | $8.02 |
| P/E Ratio | ★ N/A | $181.13 |
| Revenue Growth | N/A | ★ 20.29 |
| 52 Week Low | $14.79 | $10.73 |
| 52 Week High | $48.53 | $19.84 |
| Indicator | ELVN | NMRK |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 39.32 |
| Support Level | $16.84 | $13.51 |
| Resistance Level | $45.14 | $15.18 |
| Average True Range (ATR) | 2.38 | 0.53 |
| MACD | -0.21 | -0.22 |
| Stochastic Oscillator | 48.17 | 21.07 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.